D
Denali Therapeutics D
D
DNLI
13.880
USD
-0.20
(-1.42%)
مغلق
حجم التداول
36,281
الربح لكل سهم
-3
العائد الربحي
-
P/E
-5
حجم السوق
2,016,435,030
الأخبار المقالات
العنوان: Denali Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brainpenetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.